29 related articles for article (PubMed ID: 25616974)
21. Lower maximum standardized uptake value of fluorine-18 fluorodeoxyglucose positron emission tomography coupled with computed tomography imaging in pancreatic ductal adenocarcinoma patients with diabetes.
Chung KH; Park JK; Lee SH; Hwang DW; Cho JY; Yoon YS; Han HS; Hwang JH
Am J Surg; 2015 Apr; 209(4):709-16. PubMed ID: 25616974
[TBL] [Abstract][Full Text] [Related]
22. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
[TBL] [Abstract][Full Text] [Related]
23. Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer.
Halbrook CJ; Lyssiotis CA
Cancer Cell; 2017 Jan; 31(1):5-19. PubMed ID: 28073003
[TBL] [Abstract][Full Text] [Related]
24. Multimodality imaging of pancreatic cancer-computed tomography, magnetic resonance imaging, and positron emission tomography.
Raman SP; Horton KM; Fishman EK
Cancer J; 2012; 18(6):511-22. PubMed ID: 23187837
[TBL] [Abstract][Full Text] [Related]
25. Imaging of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography.
Alazraki N
J Gastrointest Surg; 2002; 6(2):136-8. PubMed ID: 11992797
[No Abstract] [Full Text] [Related]
26. Radiology and diabetes mellitus.
Chaudhary V; Bano S; Kalra S
J Pak Med Assoc; 2015 Apr; 65(4):435-9. PubMed ID: 25976585
[TBL] [Abstract][Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]